Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, May 21, 2014

Investigational PD-1 Immune Checkpoint Inhibitor Nivolumab Receives...

The designation is based on data from a cohort of patients with HL in the company's ongoing Phase 1b study of relapsed and refractory hematological malignancies .

http://ift.tt/1ngjajE

No comments:

Post a Comment

Popular Stem Cell Roundup Posts